Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][4]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [4]. - Investors have until March 9, 2026, to request to be appointed to lead the case [4][9]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Ardent Health securities [4]. Group 2: Allegations Against Ardent Health - The lawsuit alleges that Ardent Health misrepresented its accounts receivable collection practices, claiming to rely on "detailed reviews of historical collections," while actually using a 180-day cliff method for reserving uncollectable accounts [5]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses [5]. Group 3: Stock Performance Impact - On November 12, 2025, Ardent Health disclosed a $43 million revenue decrease for the quarter and increased its professional liability reserves by $54 million, leading to a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 on November 13, 2025 [6][9].
ARDT Investor Alert: Ardent Health Securities Fraud Class Action Focuses on Collectability Issues; BFA Law Notifies Investors of March 9 Court Deadline